Caffeine Reverses Cognitive Impairment and Decreases Brain Amyloid-β Levels in Aged Alzheimer's Disease Mice

Actions of caffeine in the brain with special reference to factors that contribute to its widespread use

Fredholm, B. B., Bättig, K., Holmén, J., Nehlig, A., & Zvartau, E. E. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01396-6 · Cited by 2,624 · cited 4× · see citing works

Introduction to NF-κB: players, pathways, perspectives

Gilmore, T. D. (2006) · Oncogene · doi:10.1038/sj.onc.1209954 · Cited by 2,227 · see citing works

Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects

Nehlig, A., Daval, J., & Debry, G. (1992) · Brain Research Reviews · doi:10.1016/0165-0173(92)90012-b · Cited by 1,463 · see citing works

The multifaceted roles of glycogen synthase kinase 3β in cellular signaling

Grimes, C. A., & Jope, R. S. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00011-9 · Cited by 1,429 · see citing works

Molecular cloning and expression of glycogen synthase kinase‐3/factor A.

Woodgett, J. R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07419.x · Cited by 1,362 · see citing works

GSK-3α regulates production of Alzheimer's disease amyloid-β peptides

Phiel, C. J., Wilson, C., Lee, V. M. ‐., & Klein, P. S. (2003) · Nature · doi:10.1038/nature01640 · Cited by 1,200 · see citing works

The GSK3 hypothesis of Alzheimer’s disease

Hooper, C., Killick, R., & Lovestone, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05194.x · Cited by 1,191 · see citing works

Coffee and Health: A Review of Recent Human Research

Higdon, J. V., & Frei, B. (2006) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390500400009 · Cited by 1,090 · cited 1× · see citing works

Decreased nuclear β‐catenin, tau hyperphosphorylation and neurodegeneration in GSK‐3β conditional transgenic mice

Lucas, J. J., Hernández, F., Gómez‐Ramos, P., Morán, M. A., Hen, R., & Avila, J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.1.27 · Cited by 903 · see citing works

A meta‐analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease

Hernán, M. A., Takkouche, B., Caamaño‐Isorna, F., & Gestal‐Otero, J. J. (2002) · Annals of Neurology · doi:10.1002/ana.10277 · Cited by 818 · cited 1× · see citing works

Association of coffee and caffeine intake with the risk of Parkinson disease

Ross, G. W. (2000) · JAMA · doi:10.1001/jama.283.20.2674 · Cited by 778 · see citing works

Caffeine as a psychomotor stimulant: mechanism of action

Fisone, G., Borgkvist, A., & Usiello, A. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3269-3 · Cited by 539 · see citing works

Microvascular injury and blood–brain barrier leakage in Alzheimer's disease

Zipser, B. D., Johanson, C. E., Gonzalez, L., Berzin, T. M., Tavares, R., Hulette, C. M., Vitek, M. P., Hovanesian, V., & Stopa, E. G. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.016 · Cited by 487 · see citing works

Caffeine protects Alzheimer’s mice against cognitive impairment and reduces brain β-amyloid production

Arendash, G. W., Schleif, W. S., Rezai-Zadeh, K. P., Jackson, E. K., Zacharia, L. C., Cracchiolo, J. R., Shippy, D. C., & Tan, J. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.07.021 · Cited by 459 · see citing works

Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment

Gong, B., Vitolo, O. V., Trinchese, F., Liu, S., Shelanski, M., & Arancio, O. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22831 · Cited by 442 · see citing works

CREB DNA binding activity is inhibited by glycogen synthase kinase‐3β and facilitated by lithium

Grimes, C. A., & Jope, R. S. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00495.x · Cited by 437 · see citing works

Midlife Coffee and Tea Drinking and the Risk of Late-Life Dementia: A Population-Based CAIDE Study

Eskelinen, M. H., Ngandu, T., Tuomilehto, J., Soininen, H., & Kivipelto, M. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-0920 · Cited by 428 · see citing works

GSK-3 is essential in the pathogenesis of Alzheimer's disease

Takashima, A. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9s335 · Cited by 395 · see citing works

Spatial learning deficit in transgenic mice that conditionally over‐express GSK‐3β in the brain but do not form tau filaments

Hernández, F., Borrell, J., Guaza, C., Avila, J., & Lucas, J. J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01269.x · Cited by 372 · see citing works

Caffeine and adenosine A2a receptor antagonists prevent β-amyloid (25–35)-induced cognitive deficits in mice

Dall'Igna, O. P. P., Neto, P. F., Gomes, M. W. S., Souza, D. O., Cunha, R. A., & Lara, D. R. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.08.008 · Cited by 372 · see citing works

Does caffeine intake protect from Alzheimer's disease?

Maia, L., & de Mendonça, A. (2002) · European Journal of Neurology · doi:10.1046/j.1468-1331.2002.00421.x · Cited by 357 · see citing works

Blood—Brain Barrier Permeability Precedes Senile Plaque Formation in an Alzheimer Disease Model

UJIIE, M., DICKSTEIN, D. L., CARLOW, D. A., & JEFFERIES, W. A. (2003) · Microcirculation · doi:10.1038/sj.mn.7800212 · Cited by 351 · see citing works

The neuroprotective effects of caffeine: A prospective population study (the Three City Study)

Ritchie, K., Carrière, I., de Mendonça, A., Portet, F., Dartigues, J. F., Rouaud, O., Barberger-Gateau, P., & Ancelin, M. L. (2007) · Neurology · doi:10.1212/01.wnl.0000266670.35219.0c · Cited by 347 · see citing works

Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States

Ruhl, C. E., & Everhart, J. E. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.09.075 · Cited by 275 · see citing works

Full Reversal of Alzheimer's Disease-Like Phenotype in a Mouse Model with Conditional Overexpression of Glycogen Synthase Kinase-3

Engel, T., Hernández, F., Ávila, J., & Lucas, J. J. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0604-06.2006 · Cited by 261 · see citing works

Caffeine analogs: biomedical impact

Daly, J. W. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7051-9 · Cited by 259 · see citing works

Neuroprotection by caffeine and adenosine A 2A receptor blockade of β ‐amyloid neurotoxicity

Dall'lgna, O. P., Porciúncula, L. O., Souza, D. O., Cunha, R. A., & Lara, D. R. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705185 · Cited by 255 · see citing works

Positive and negative regulation of Raf kinase activity and function by phosphorylation

Kopera, H. C., Lee, J., & Guan, K. (2001) · The EMBO Journal · doi:10.1093/emboj/20.14.3716 · Cited by 255 · see citing works

Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months

King, D. L., & Arendash, G. W. (2002) · Physiology & Behavior · doi:10.1016/s0031-9384(02)00639-x · Cited by 240 · see citing works

Environmental enrichment improves cognition in aged Alzheimer's transgenic mice despite stable β-amyloid deposition

Arendash, G. W., Garcia, M. F., Costa, D. A., Cracchiolo, J. R., Wefes, I., & Potter, H. (2004) · Neuroreport · doi:10.1097/01.wnr.0000137183.68847.4e · Cited by 237 · see citing works

Antioxidant and prooxidant properties of caffeine, theobromine and xanthine.

Azam, S., Hadi, N., Khan, N. U.-D., & Hadi, S. M. (2003) · PubMed · Cited by 234 · see citing works

Coffee consumption is inversely associated with cognitive decline in elderly European men: the FINE Study

van Gelder, B. M., Buijsse, B., Tijhuis, M., Kalmijn, S., Giampaoli, S., Nissinen, A., & Kromhout, D. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602495 · Cited by 228 · see citing works

The role of Raf kinase inhibitor protein (RKIP) in health and disease

Keller, E. T., Fu, Z., & Brennan, M. M. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.04.024 · Cited by 221 · see citing works

Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice

Tan, J., Town, T., Crawford, F., Mori, T., DelleDonne, A., Crescentini, R., Obregon, D., Flavell, R. A., & Mullan, M. J. (2002) · Nature Neuroscience · doi:10.1038/nn968 · Cited by 217 · see citing works

Enrichment improves cognition in AD mice by amyloid-related and unrelated mechanisms

Costa, D. A., Cracchiolo, J. R., Bachstetter, A. D., Hughes, T. F., Bales, K. R., Paul, S. M., Mervis, R. F., Arendash, G. W., & Potter, H. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.04.009 · Cited by 217 · see citing works

Differential regulation of BACE1 promoter activity by nuclear factor‐κB in neurons and glia upon exposure to β‐amyloid peptides

Bourne, K. Z., Ferrari, D. C., Lange‐Dohna, C., Roßner, S., Wood, T. G., & Perez-Polo, J. R. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21252 · Cited by 188 · see citing works

Kappa B site-dependent induction of gene expression by diverse inducers of nuclear factor kappa B requires Raf-1.

Finco, T. S., & Baldwin, A. S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46756-1 · Cited by 186 · see citing works

Regulation of Raf‐1 kinase activity by the 14‐3‐3 family of proteins.

Li, S., Janosch, P., Tanji, M., et al. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07047.x · Cited by 162 · see citing works

Enhanced cognitive activity--over and above social or physical activity--is required to protect Alzheimer's mice against cognitive impairment, reduce Abeta deposition, and increase synaptic immunoreactivity.

Cracchiolo, J. R., Mori, T., Nazian, S., Tan, J., Potter, H., & Arendash, G. (2007) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2007.07.007 · Cited by 161 · see citing works

Flavonoid‐mediated presenilin‐1 phosphorylation reduces Alzheimer's disease β‐amyloid production

Rezai-Zadeh, K. P., Shytle, R. D., Bai, Y., Tian, J., Hou, H., Mori, T., Zeng, J., Obregon, D. F., Town, T., & Tan, J. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00344.x · Cited by 153 · see citing works

NF‐κB pathway: a target for preventing β‐amyloid (Aβ)‐induced neuronal damage and Aβ42 production

Valerio, A., Boroni, F., Benarese, M., Sarnico, I., Ghisi, V., Bresciani, L. G., Ferrario, M., Borsani, G., Spano, P., & Pizzi, M. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04722.x · Cited by 148 · see citing works

Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer's disease

Chen, X., Gawryluk, J. W., Wagener, J. F., Ghribi, O., & Geiger, J. D. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-12 · Cited by 147 · see citing works

Multi-metric behavioral comparison of APPsw and P301L models for Alzheimer's disease: linkage of poorer cognitive performance to tau pathology in forebrain

Arendash, G. W., Lewis, J., Leighty, R. E., McGowan, E., Cracchiolo, J. R., Hutton, M., & Garcia, M. F. (2004) · Brain Research · doi:10.1016/j.brainres.2004.02.081 · Cited by 127 · see citing works

Adenosine A2A receptor blockade prevents memory dysfunction caused by β-amyloid peptides but not by scopolamine or MK-801

Cunha, G. M. A., Canas, P. M., Melo, C. S., Hockemeyer, J., Müller, C. E., Oliveira, C. R., & Cunha, R. A. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.11.013 · Cited by 109 · see citing works

Caffeine suppresses TNF-α production via activation of the cyclic AMP/protein kinase A pathway

Horrigan, L. A., Kelly, J. P., & Connor, T. J. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2004.06.005 · Cited by 108 · see citing works

A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer’s transgenic mice

Arendash, G. W., Jensen, M. T., Salem, N., Hussein, N., Cracchiolo, J. R., Dickson, A., Leighty, R. E., & Potter, H. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.08.018 · Cited by 103 · see citing works

Caffeine-Mediated Presynaptic Long-Term Potentiation in Hippocampal CA1 Pyramidal Neurons

Martín, E. D., & Buño, W. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00601.2002 · Cited by 94 · see citing works

The inflammation-induced pathological chaperones ACT and apo-E are necessary catalysts of Alzheimer amyloid formation

Potter, H. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00308-6 · Cited by 87 · see citing works

Presenilin‐1 is an unprimed glycogen synthase kinase‐3β substrate

Twomey, C., & McCarthy, J. V. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.06.035 · Cited by 78 · see citing works

Nilvadipine antagonizes both Aβ vasoactivity in isolated arteries, and the reduced cerebral blood flow in APPsw transgenic mice

Paris, D., Quadros, A., Humphrey, J., Patel, N. S., Crescentini, R. M., Crawford, F., & MULLAN, M. J. (2004) · Brain Research · doi:10.1016/j.brainres.2003.11.061 · Cited by 75 · see citing works

Aβ-specific T-cells reverse cognitive decline and synaptic loss in Alzheimer's mice

Ethell, D. W., Shippy, D. C., Cao, C., Cracchiolo, J. R., Runfeldt, M. J., Blake, B., & Arendash, G. W. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.03.008 · Cited by 70 · see citing works

Sorafenib inhibits nuclear factor kappa B, decreases inducible nitric oxide synthase and cyclooxygenase-2 expression, and restores working memory in APPswe mice

Echeverrı́a, V., Burgess, S., Gamble‐George, J., Zeitlin, R., Lin, X., Cao, C., & Arendash, G. W. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.05.019 · Cited by 70 · see citing works

Lifelong immunization with human β-amyloid (1–42) protects Alzheimer's transgenic mice against cognitive impairment throughout aging

Jensen, M. T., Mottin, M. D., Cracchiolo, J. R., Leighty, R. E., & Arendash, G. W. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.09.055 · Cited by 69 · see citing works

Review: Caffeine: Neuroprotective Functions in Cognition and Alzheimer's Disease

Rosso, A. L., Mossey, J. M., & Lippa, C. F. (2008) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317508320083 · Cited by 67 · see citing works

Arundic Acid Ameliorates Cerebral Amyloidosis and Gliosis in Alzheimer Transgenic Mice

Mori, T., Town, T., Tan, J., Yada, N., Horikoshi, Y., Yamamoto, J., Shimoda, T., Kamanaka, Y., Tateishi, N., & Asano, T. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.105171 · Cited by 67 · see citing works

Caffeine and the Elderly

Massey, L. K. (1998) · Drugs & Aging · doi:10.2165/00002512-199813010-00005 · Cited by 60 · see citing works

Characterization of interior cleavage of retinoblastoma protein in apoptosis

Fattman, C. L., An, B., & Dou, Q. P. (1997) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19971201)67:3 · Cited by 49 · see citing works

Use of multimetric statistical analysis to characterize and discriminate between the performance of four Alzheimer’s transgenic mouse lines differing in Aβ deposition

Leighty, R. E., Nilsson, L. N. G., Potter, H., Costa, D. A., Low, M. A., Bales, K. R., Paul, S. M., & Arendash, G. W. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2003.11.004 · Cited by 47 · see citing works

Neonatal caffeine administration causes a permanent increase in the dendritic length of prefrontal cortical neurons of rats

Juárez‐Méndez, S., Carretero, R. G., Martínez‐Téllez, R. I., Gómez, A. B. S., & Flores, G. (2006) · Synapse · doi:10.1002/syn.20318 · Cited by 46 · see citing works

Short-term β-amyloid vaccinations do not improve cognitive performance in cognitively impaired APP+PS1 mice.

Austin, L. A., Arendash, G. W., Gordon, M. N., Diamond, D. M., DiCarlo, G., Dickey, C. A., Ugen, K. E., & Morgan, D. (2003) · Behavioral Neuroscience · doi:10.1037/0735-7044.117.3.478 · Cited by 45 · see citing works

Distribution, levels and phosphorylation of Raf‐1 in Alzheimer's disease

Mei, M., Su, B., Harrison, K. H., Chao, M. P., Siedlak, S., Previll, L. A., Jackson, L., Cai, D., & Zhu, X.-W. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04174.x · Cited by 34 · see citing works

Caffeine inhibits post-tetanic potentiation but does not alter long-term potentiation in the rat hippocampal slice

Lee, W.-L., Anwyl, R., & Rowan, M. J. (1987) · Brain Research · doi:10.1016/0006-8993(87)90879-1 · Cited by 31 · see citing works

Caffeine stimulates the proliferation of human lung adenocarcinoma cells and small airway epithelial cells via activation of PKA, CREB and ERK1/2

Al-Wadei, H. A. N., Takahashi, T., & Schuller, H. M. (2006) · Oncology Reports · doi:10.3892/or.15.2.431 · Cited by 24 · see citing works

Promotion of forskolin-induced long-term potentiation of synaptic transmission by caffeine in area CA1 of the rat hippocampus.

Lu, K., Wu, S. P., & Gean, P. W. (1999) · PubMed · Cited by 13 · see citing works

Use of artificial neural networks to determine cognitive impairment and therapeutic effectiveness in Alzheimer's transgenic mice

Leighty, R. E., Runfeldt, M. J., Berndt, D. J., Schleif, W. S., Cracchiolo, J. R., Potter, H., & Arendash, G. W. (2007) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2007.08.008 · Cited by 9 · see citing works

The Safety of Ingested Caffeine: A Comprehensive Review

Temple, J. L., Bernard, C., Lipshultz, S. E., Czachor, J. D., Westphal, J. A., & Mestre, M. A. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00080 · Cited by 557 · see citing works

The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy

McGeer, P. L., & McGeer, E. G. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1177-7 · Cited by 467 · see citing works

Nutrition, physical activity, and other lifestyle factors in the prevention of cognitive decline and dementia

Dominguez, L. J., Veronese, N., Vernuccio, L., Catanese, G., Inzerillo, F., Salemi, G., & Barbagallo, M. (2021) · Nutrients · doi:10.3390/nu13114080 · Cited by 433 · see citing works

Adenosine receptors and brain diseases: neuroprotection and neurodegeneration

Gomes, C. V., Kaster, M. P., Tomé, A. R., Agostinho, P. M., & Cunha, R. A. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.12.001 · Cited by 419 · see citing works

Health Benefits and Chemical Composition of Matcha Green Tea: A Review

Kochman, J., Jakubczyk, K., Antoniewicz, J., Mruk, H., & Janda, K. (2020) · Molecules · doi:10.3390/molecules26010085 · Cited by 328 · see citing works

The role of CREB signaling in Alzheimer’s disease and other cognitive disorders

Saura, C. A., & Valero, J. (2011) · revneuro · doi:10.1515/rns.2011.018 · Cited by 312 · see citing works

Natural Compounds for Alzheimer’s Disease Therapy: A Systematic Review of Preclinical and Clinical Studies

Andrade, S., Ramalho, M. J., Loureiro, J. A., & Pereira, M. D. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092313 · Cited by 240 · see citing works

Lifestyle Modifications and Nutritional Interventions in Aging-Associated Cognitive Decline and Alzheimer's Disease

Bhatti, G. K., Reddy, A. P., Reddy, P. H., & Bhatti, J. S. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00369 · Cited by 145 · see citing works

Coffee Intake in Midlife and Risk of Dementia and its Neuropathologic Correlates

Gelber, R. P., Petrovitch, H., Masaki, K. H., Ross, G. W., & White, L. R. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-101428 · Cited by 133 · see citing works

The Effect of Caffeine on the Risk and Progression of Parkinson’s Disease: A Meta-Analysis

Hong, C. T., Chan, L., & Bai, C.-H. (2020) · Nutrients · doi:10.3390/nu12061860 · Cited by 113 · see citing works

Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview

Libro, R., Giacoppo, S., Soundara Rajan, T., Bramanti, P., & Mazzon, E. (2016) · Molecules · doi:10.3390/molecules21040518 · Cited by 107 · see citing works

Crude caffeine reduces memory impairment and amyloid β1–42 levels in an Alzheimer’s mouse model

Chu, Y.-F., Chang, W.-H., Black, R. M., Liu, J.-R., Sompol, P., Chen, Y., Wei, H., Zhao, Q., & Cheng, I. H. (2012) · Food Chemistry · doi:10.1016/j.foodchem.2012.04.148 · Cited by 106 · see citing works

Caffeine and the Control of Cerebral Hemodynamics

Pelligrino, D. A., Xu, H.-L., & Vetri, F. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091261 · Cited by 93 · see citing works

Coffee intake and decreased amyloid pathology in human brain

Kim, J. W., Byun, M. S., Yi, D., Lee, J. H., Jeon, S. Y., Jung, G., Lee, H. N., Sohn, B. K., Lee, J.-Y., Kim, Y. K., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0604-5 · Cited by 86 · see citing works

Coffee Consumption Habits and the Risk of Mild Cognitive Impairment: The Italian Longitudinal Study on Aging

Solfrizzi, V., and for the Italian Longitudinal Study on Aging Working Group 2, Panza, F., Imbimbo, B. P., D’Introno, A., Galluzzo, L., Gandin, C., Misciagna, G., Guerra, V., Osella, A., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150333 · Cited by 65 · see citing works

Association between tea consumption and risk of cognitive disorders: a dose-response meta-analysis of observational studies

Liu, X., Du, X., Han, G., & Gao, W. (2017) · Oncotarget · doi:10.18632/oncotarget.17429 · Cited by 60 · see citing works

Relationships Between Caffeine Intake and Risk for Probable Dementia or Global Cognitive Impairment: The Women’s Health Initiative Memory Study

Driscoll, I., Shumaker, S. A., Snively, B. M., Margolis, K. L., Manson, J. E., Vitolins, M. Z., Rossom, R. C., & Espeland, M. A. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glw078 · Cited by 55 · see citing works

Caffeine, Cognitive Functioning, and White Matter Lesions in the Elderly: Establishing Causality from Epidemiological Evidence

Ritchie, K., Artero, S., Portet, F., Brickman, A., Muraskin, J., Beanino, E., Ancelin, M.-L., & Carrière, I. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1387 · Cited by 45 · see citing works

Differential Behavioral and Biochemical Responses to Caffeine in Male and Female Rats from a Validated Model of Attention Deficit and Hyperactivity Disorder

Nunes, F., Pochmann, D., Almeida, A. S., Marques, D. M., & Porciúncula, L. D. O. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1000-5 · Cited by 26 · see citing works

Chronic Caffeine Exposure Attenuates Blast-Induced Memory Deficit in Mice

Ning, Y.-L., Yang, N., Chen, X., Zhao, Z.-A., Zhang, X.-Z., Chen, X.-Y., Li, P., Zhao, Y., & Zhou, Y.-G. (2015) · Chinese Journal of Traumatology · doi:10.1016/j.cjtee.2015.10.003 · Cited by 24 · see citing works

Roasted Coffee Reduces β‐Amyloid Production by Increasing Proteasomal β‐Secretase Degradation in Human Neuroblastoma SH‐SY5Y Cells

Fukuyama, K., Kakio, S., Nakazawa, Y., Kobata, K., Funakoshi‐Tago, M., Suzuki, T., & Tamura, H. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800238 · Cited by 22 · see citing works

Susquehanna Chorale Spring Concert "Roots and Wings"

Hawkins, D. (2017)

Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation

Chui, D.-H., Tanahashi, H., Ozawa, K., Ikeda, S., Checler, F., Ueda, O., Suzuki, H., Araki, W., Inoue, H., Shirotani, K., et al. (1999) · Nature Medicine · doi:10.1038/8438 · Cited by 364 · see citing works

Presenilin 1 transgene addition to amyloid precursor protein overexpressing transgenic rats increases amyloid beta 42 levels and results in loss of memory retention

Agca, C., Klakotskaia, D., Schachtman, T. R., Chan, A. W. S., Lah, J. J., & Ağca, Y. (2016) · BMC Neuroscience · doi:10.1186/s12868-016-0281-8 · Cited by 21 · see citing works

Hippocampal Neuron Loss Exceeds Amyloid Plaque Load in a Transgenic Mouse Model of Alzheimer's Disease

Schmitz, C., Rutten, B. P. F., Pielen, A., Schäfer, S., Wirths, O., Tremp, G., Czech, C., Blanchard, V., Multhaup, G., Rezaie, P., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63235-x · Cited by 281 · see citing works

Lack of human-like extracellular sortilin neuropathology in transgenic Alzheimer’s disease model mice and macaques

Zhou, F., Jiang, J., Griffith, C. M., Patrylo, P. R., Cai, H., Chu, Y., & Yan, X. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0370-2 · Cited by 25 · see citing works